Filed: 5/12/2023ACC: 0001104659-23-059762
📋 What this filing means
NEXTECH INVEST LTD. filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $239.57M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$239.57M
Total AUM (reported)
29.80M
Total Shares
Allocation by class
COM$238.39M99.5%
COM STK$1.18M0.5%
Portfolio Concentration
Top 3$170.72M71.3%
4–10$65.55M27.4%
11–25$3.30M1.4%
Top 3 weight
71.3%
Top 10 weight
98.6%
Voting Authority Distribution
Total shares with voting rights: 29.80M
Sole
Full voting authority
29.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
REVOLUTION MEDICINES INC
SOLEShares4.84M
TypeSH
Market value$104.82M
43.76%
Sole
4.84M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares2.52M
TypeSH
Market value$40.47M
16.89%
Sole
2.52M
Shared
0.00
None
0.00
EQRX INC
SOLEShares13.10M
TypeSH
Market value$25.42M
10.61%
Sole
13.10M
Shared
0.00
None
0.00
KINNATE BIOPHARMA INC
SOLEShares2.33M
TypeSH
Market value$14.56M
6.08%
Sole
2.33M
Shared
0.00
None
0.00
CULLINAN ONCOLOGY INC
SOLEShares1.22M
TypeSH
Market value$12.49M
5.21%
Sole
1.22M
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
SOLEShares1.91M
TypeSH
Market value$12.43M
5.19%
Sole
1.91M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares625.49K
TypeSH
Market value$10.30M
4.30%
Sole
625.49K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares287.25K
TypeSH
Market value$7.85M
3.28%
Sole
287.25K
Shared
0.00
None
0.00
THESEUS PHARMACEUTICALS INC
SOLEShares611.31K
TypeSH
Market value$5.43M
2.27%
Sole
611.31K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares521.28K
TypeSH
Market value$2.49M
1.04%
Sole
521.28K
Shared
0.00
None
0.00
KRONOS BIO INC
SOLEShares1.45M
TypeSH
Market value$2.12M
0.88%
Sole
1.45M
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares375.86K
TypeSH
Market value$1.18M
0.49%
Sole
375.86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 4.84M | SH | $104.82M 43.76% | 4.84M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 2.52M | SH | $40.47M 16.89% | 2.52M | 0.00 | 0.00 |
EQRX INCSOLE | COM | 13.10M | SH | $25.42M 10.61% | 13.10M | 0.00 | 0.00 |
KINNATE BIOPHARMA INCSOLE | COM | 2.33M | SH | $14.56M 6.08% | 2.33M | 0.00 | 0.00 |
CULLINAN ONCOLOGY INCSOLE | COM | 1.22M | SH | $12.49M 5.21% | 1.22M | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCSOLE | COM | 1.91M | SH | $12.43M 5.19% | 1.91M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 625.49K | SH | $10.30M 4.30% | 625.49K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 287.25K | SH | $7.85M 3.28% | 287.25K | 0.00 | 0.00 |
THESEUS PHARMACEUTICALS INCSOLE | COM | 611.31K | SH | $5.43M 2.27% | 611.31K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 521.28K | SH | $2.49M 1.04% | 521.28K | 0.00 | 0.00 |
KRONOS BIO INCSOLE | COM | 1.45M | SH | $2.12M 0.88% | 1.45M | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 375.86K | SH | $1.18M 0.49% | 375.86K | 0.00 | 0.00 |